Teva introduces a generic of Acanya
JERUSALEM, Israel —Teva Pharmaceuticals announces the introduction and availability of clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. This product is AB rated and bioequivalent to Acanya (Clindamycin Phosphate and Benzoyl Peroxide) Gel. Teva Pharmaceuticals USA, Inc. is a wholly-owned subsidiary of Israeli-based Teva Pharmaceutical Industries Ltd., one of the leading pharmaceutical companies in the world. Teva
